Novazyme

Genzyme Completes Acquisition of Novazyme Pharmaceuticals CAMBRIDGE, MA, September 27, 2001—Genzyme Corp. announced today that it has completed the acquisition Read more...

Genzyme to Acquire Novazyme Pharmaceuticals Proprietary Glycoprotein Technology Platform Will Advance Lysosomal Storage Disorder Programs CAMBRIDGE Read more...

Novazyme Pharmaceuticals Raises $8.0 Million Through Private Equity Placement Funds to Further Accelerate Development of Multiple Lysosomal Storage Disease Read more...